2003 Discharge: European Agency for the Evaluation of Medicinal Products

This procedure concerns the European Parliament's approval of how the European Agency for the Evaluation of Medicinal Products managed its budget in 2003. It's part of the annual 'discharge' process, ensuring accountability and transparency in EU spending.

This decision affects the agency's financial management and future budget planning. It provides a review of its performance and adherence to financial rules.